Purchase Order 36C24823P1173

Award Date 4/5/23
Potential Completion Date 4/13/23
Potential Value $31K
Ultimate Awardee
Cardinal Health, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 8 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $31,018.03 order is for emergency delivery of the radiopharmaceutical Xofigo for two patients. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to federal health agencies including the VA, Department...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $15,863.85 firm-fixed-price purchase order to Cardinal Health 414, LLC for the delivery of an emergency dose of the radiopharmaceutical Xofigo. Cardinal Health 414, LLC is a subsidiary of the global healthcare company Cardinal Health, Inc. that specializes in providing radiopharmaceuticals and other medical products to federal agencies such as the VA, Department of Defense, and...
This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to Cardinal Health 414, LLC, a subsidiary of the healthcare services company Cardinal Health, Inc. The contract, valued at $15,787.43, is for the delivery of the radiopharmaceutical therapy Xofigo to support emergency patient care. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialty...
This is a firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the radiopharmaceutical Xofigo, used in the treatment of prostate cancer. The contract has a potential value of $12,970.58 and a completion date of February 10, 2023. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and other...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $15,711 firm-fixed-price purchase order to Cardinal Health 414, LLC for the delivery of the radiopharmaceutical Xofigo. Cardinal Health 414, LLC is a subsidiary of the global healthcare services company Cardinal Health, Inc. and a major supplier of radiopharmaceuticals and nuclear medicine products to federal health agencies. This award is part of Cardinal Health 414's broader...
This federal contract award, valued at $261,303.00, was issued by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the supply of the radiopharmaceutical product Xofigo (radium-223 dichloride). The contract is a firm fixed-price purchase order with an ultimate completion date of April 11, 2026. Cardinal Health 414, LLC is a subsidiary of the larger Cardinal Health, Inc., a global healthcare services company that...
This is a $180,765.47 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the radiopharmaceutical product XOFIGO to support nuclear medicine and oncology programs at VA medical facilities. Cardinal Health 414 has provided a range of pharmaceutical products and services to the VA, Department of Defense, National Institutes of...
This firm fixed-price purchase order contract was awarded by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $64,325.92 and is for the delivery of the radiopharmaceutical Xofigo (radium-223 dichloride) to support nuclear medicine and oncology services for the VA healthcare system. The contract has an ultimate completion date of...
This is a $83,833.25 firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of Xofigo (radium-223 dichloride), a radiopharmaceutical product used in the treatment of prostate cancer. The contract has an ultimate completion date of April 15, 2016. Cardinal Health 414 is an established government healthcare supplier, holding numerous indefinite delivery vehicle (IDV) contracts...
This is a $32,295.44 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC for the delivery of XOFIGO RA 223, a radiopharmaceutical product, with a completion date of February 29, 2024. Cardinal Health 414, LLC is a subsidiary of the global healthcare company Cardinal Health, Inc. and has previously received numerous indefinite delivery contracts from the VA and other federal health agencies to provide a...

This is a $31,018.03 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the emergency supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. Cardinal Health 414 is a subsidiary of the global healthcare services company Cardinal Health, Inc. and specializes in providing radiopharmaceuticals and related products to federal agencies, including the VA, Department of Defense, and National Institutes of Health. This order is not associated with a set-aside program. Cardinal Health 414 holds several Indefinite Delivery Vehicles (IDVs) with the VA, valued up to $39.8 million, that allow for the ongoing supply of a wide range of radiopharmaceuticals to VA medical facilities nationwide. The company's expertise in handling and distributing time-sensitive, radioactive medical products is critical to supporting the VA's nuclear medicine capabilities and providing comprehensive healthcare services to veterans.

Generated 1/4/25, 9:01 AM